Bobin C, Ingrand P, Dréno B, Rio E, Malard O, Espitalier F
Service d'ORL et CCF, CHUNantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.
Centre d'investigation clinique, CHUPoitiers, 2, rue de la Milétrie, 86021 Poitiers, France.
Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Apr;135(2):99-103. doi: 10.1016/j.anorl.2017.09.006. Epub 2017 Nov 1.
Cutaneous squamous cell carcinoma (CSCC) develops on the head in 80% of cases. Parotid metastasis (PM) is rare, but treatment, which associates surgery and radiation therapy, is heavy and prognosis poor.
All cases of parotidectomy for PM of CSCC of the head and neck between 2005 and 2015 were studied retrospectively. Epidemiologic, oncologic and therapeutic data were analyzed. Overall and specific survival were calculated following Kaplan-Meier. Log-rank and Cox models were used to identify prognostic factors for PM.
The principal study objective was to identify factors for survival in PM from CSCC of the head and neck.
Thirty-five patients were included. Mean time to onset of PM was 13months. Overall 1-, 2- and 5-year survival was respectively 70, 66 and 59%. Independent prognostic factors comprised immunodepression, age at treatment, positive CSCC margins, macroscopic facial nerve involvement, and metastatic cervical adenopathies.
The study confirmed an association of several independent prognostic factors at the stage of parotid lymph-node metastasis, related to patient, primary CSCC and PM. Complete primary resection is essential to reduce the risk of PM. Intensified radiologic and clinical surveillance should enable early diagnosis.
80%的皮肤鳞状细胞癌(CSCC)发生于头部。腮腺转移(PM)罕见,但治疗需联合手术和放疗,治疗负担重且预后差。
回顾性研究2005年至2015年间因头颈部CSCC的PM而行腮腺切除术的所有病例。分析流行病学、肿瘤学和治疗数据。采用Kaplan-Meier法计算总生存率和特异性生存率。使用对数秩检验和Cox模型确定PM的预后因素。
主要研究目的是确定头颈部CSCC的PM患者的生存因素。
纳入35例患者。PM发病的平均时间为13个月。1年、2年和5年总生存率分别为70%、66%和59%。独立预后因素包括免疫抑制、治疗时的年龄、CSCC切缘阳性、面神经肉眼受累以及转移性颈淋巴结病。
该研究证实了在腮腺淋巴结转移阶段有几个独立预后因素之间的关联,这些因素与患者、原发性CSCC和PM相关。完整的原发灶切除对于降低PM风险至关重要。加强影像学和临床监测应能实现早期诊断。